Omega Healthcare Investors, Inc.

NYSE:OHI Lagerbericht

Marktkapitalisierung: US$8.6b

Omega Healthcare Investors Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Omega Healthcare InvestorsDie Umsatzerlöse des Unternehmens werden voraussichtlich um 1.6% pro Jahr zurückgehen, während die jährlichen Gewinne voraussichtlich um 11.5% pro Jahr wachsen werden. Der Gewinn pro Aktie wird voraussichtlich um 10.1% pro Jahr wachsen. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 11.1% betragen.

Wichtige Informationen

11.7%

Wachstumsrate der Gewinne

10.1%

EPS-Wachstumsrate

Health Care REITs Gewinnwachstum30.1%
Wachstumsrate der Einnahmen-1.4%
Zukünftige Eigenkapitalrendite11.1%
Analystenabdeckung

Good

Zuletzt aktualisiert25 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Omega Healthcare Investors: 8.4% Yield And Selling Below Fair Price

Jun 14

Omega Healthcare: You May Want To Wait For A Better Price

Jun 03

Omega Healthcare: Clarity Regarding The Dividend Makes This 8.75% REIT Interesting

May 21

Omega Healthcare: Better Options In The Healthcare Space For Dividend Investors

Apr 13

Omega Healthcare Investors: How Safe Is The 9% Yield

Mar 28

Omega Healthcare: Mr. Market Liked 2024 Guidance As The 8.55% Yield Remains Intact

Feb 26

Omega Healthcare: This 9% Yield Is Not Safe

Jan 23

Omega Healthcare Has Retraced As REITs Rallied Pushing The Yield To 8.71%

Dec 22

Omega Healthcare Investors: Re-Adding This 8.4% Yielding Healthcare REIT On The Dip

Nov 29

Omega Healthcare: High Yield 8+% Stock That Keeps On Paying

Nov 14

Omega Healthcare: Time To Stop Adding This Passive Income Generator (Downgrade)

Oct 09

Should You Buy Omega Healthcare Investors For Its 8.5% Yield?

Sep 08

Omega Healthcare: The Power Of A Well-Covered High-Yield

Aug 15

Omega Healthcare Has Been Heating Up, And The Dividend Keep Coming

Jul 18

Omega Healthcare: Why The Stock Is A Hold

Jun 14

9.4%-Yielding Omega Healthcare: A Bargain With Upside Potential

May 25

Omega Healthcare Investors FFO of $0.73 beats by $0.02, revenue of $144.85M misses by $25.77M

Feb 02

Omega Healthcare Investors declares $0.67 dividend

Jan 26

Omega Healthcare Investors sees EBITDA, funds available for distribution declining in Q1

Jan 09

Omega Healthcare: Buy The Drop On This 10% Yield

Jan 01

Omega Healthcare Q3: 8% Yielding Dividend Machine Provided Positive Guidance For Income Investors

Nov 14

Omega Healthcare Investors declares $0.67 dividend

Oct 21

9%-Yielding Omega Healthcare Is Too Good To Pass Up

Oct 14

Realty Income Shares Have Gone Nowhere For 6 Plus Years

Sep 28

Omega Healthcare: Financial Strength Of Tenants Improved And Aging Demographics Are Positive

Sep 13

Omega Healthcare: 8.2% Yield, Good Coverage, Low Valuation

Aug 24

Omega Healthcare Q2 And Our Patience Test

Aug 11

What's in store for Omega Healthcare Investors Q2 Earnings?

Jul 29

Omega Healthcare Investors declares $0.67 dividend

Jul 21

Omega Healthcare Investors: Mostly Medicaid Long-Term Care

Jul 09

Omega Healthcare Investors: A REIT For Income With 9% Yield And Improving Cash Flow

Jun 08

Omega Healthcare: A Look Past COVID

May 24

Omega Healthcare Investors: Buy This Cheap 9.3% Yielding Trust For Passive Income

May 06

Omega Healthcare Investors Has A 10% Dividend Yield Which Is Too Cheap To Ignore

Apr 22

Omega Healthcare Investors: Darkest Before Dawn

Apr 12

Omega Healthcare: Bull Thesis Confirmed By 2 Independent Assessments

Mar 18

Omega Healthcare Investors: The 9.3% Yield Is Safe (For Now)

Feb 16

Gewinn- und Umsatzwachstumsprognosen

NYSE:OHI - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/2026910409N/AN/A4
12/31/2025886391N/AN/A8
12/31/2024837337N/AN/A8
3/31/2024975274658658N/A
12/31/2023950242618618N/A
9/30/2023855233606606N/A
6/30/2023853244602602N/A
3/31/2023847273605605N/A
12/31/2022878427626626N/A
9/30/2022983415629629N/A
6/30/20221,026451649649N/A
3/31/20221,038446678678N/A
12/31/20211,063417722722N/A
9/30/20211,077445763763N/A
6/30/2021914215757757N/A
3/31/2021913229745745N/A
12/31/2020892159708708N/A
9/30/2020875157659659N/A
6/30/2020989388618618N/A
3/31/2020958361583583N/A
12/31/2019929341554554N/A
9/30/2019902344557557N/A
6/30/2019891262548548N/A
3/31/2019885267557557N/A
12/31/2018882282499499N/A
9/30/2018883282499499N/A
6/30/201888193531531N/A
3/31/201889780518518N/A
12/31/2017908100N/A578N/A
9/30/2017922162N/A595N/A
6/30/2017927373N/A602N/A
3/31/2017920415N/A610N/A
12/31/2016901366N/A625N/A
9/30/2016877303N/A598N/A
6/30/2016854304N/A558N/A
3/31/2016823237N/A488N/A
12/31/2015744225N/A449N/A
9/30/2015664221N/A401N/A
6/30/2015593203N/A364N/A
3/31/2015517209N/A363N/A
12/31/2014505221N/A338N/A
9/30/2014485212N/A339N/A
6/30/2014457188N/A325N/A
3/31/2014438190N/A300N/A
12/31/2013419173N/A280N/A
9/30/2013403159N/A251N/A
6/30/2013386151N/A235N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: OHIDas prognostizierte Gewinnwachstum (11.5% pro Jahr) liegt über der Sparquote (2.4%).

Ertrag vs. Markt: OHIDie Erträge des Unternehmens (11.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.8% pro Jahr).

Hohe Wachstumserträge: OHIDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: OHIDie Einnahmen des Unternehmens werden in den nächsten 3 Jahren voraussichtlich zurückgehen (-1.6% pro Jahr).

Hohe Wachstumseinnahmen: OHIDie Einnahmen des Unternehmens werden in den nächsten drei Jahren voraussichtlich zurückgehen (-1.6% pro Jahr).

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: OHIDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (11.1%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y